HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
USFDA concludes inspection at Solara’s Ambernath facility
May-10-2025

US Food and Drug Administration (USFDA) has completed the inspection at Solara Active Pharma Science’s multi-product manufacturing facility at Ambernath, Maharashtra. The inspection established that the site is in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The Agency with their designated investigator inspected the facility from May 5th to 9th 2025. Solara continues to stay focused on maintaining the highest level of compliance across its manufacturing facilities.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

  RELATED NEWS >>